Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-6 Receptor Subunit Alpha (IL6R)
- Target
- IL6R
- Molecular classification
- Type I cytokine receptor, Receptor, Single-pass transmembrane protein
01
Overview
The interleukin-6 receptor subunit alpha (IL6R), also known as CD126, is a type I cytokine receptor and forms part of the functional IL-6 receptor complex. It binds interleukin 6 (IL‑6) with low affinity; signal transduction requires association with gp130/IL‑6ST. IL6R exists in both membrane-bound and soluble forms. It regulates immune response, acute-phase reactions, hematopoiesis, cell growth/differentiation, and tissue regeneration and is implicated in multiple diseases including autoimmune diseases and cancer. Therapeutic targeting includes monoclonal antibodies and small molecule antagonists.
- Other names
- CD126IL-6R alphaIL6RA
02
Mechanism of action
Monoclonal antibody or small molecule antagonist binding to IL-6R, blocking IL-6 signaling and subsequent downstream pathway activation, such as JAK/STAT
03
Biological functions
Immune response regulationAcute-phase reaction regulationHematopoiesisCell growth and differentiationTissue regenerationSignal transduction
04
Disease associations
Autoimmune diseasesMultiple myelomaProstate cancerRheumatoid arthritisCastleman’s diseasePsoriasisPost-menopausal osteoporosisInflammation
05
Interacting drugs
Tocilizumab
3 more in the full profile.
Beyond the preview
Go deeper on Interleukin-6 Receptor Subunit Alpha (IL6R).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Interleukin-6 Receptor Subunit Alpha (IL6R).